- Citations, last 5 years
- 273
- Works, last 5 years
- 31
- h-index
- 103
- Scientists listed
- 3
- Grants since 2016
- 17
Grants received
2025–2027 · research · R44
Development of a Drug Candidate for the Treatment of Agitation in Alzheimer's Disease
Jodi Ellen Gresack · Psychogenics (United States) · funded by National Institutes of Health
2024–2026 · research · R44
EEG Signature Analysis for Drug Repurposing for Rare Diseases
Daniela Brunner · Psychogenics (United States) · funded by National Institutes of Health
2024–2026 · contract · N01
SCREENING OF INVESTIGATIONAL AGENTS THROUGH THE NINDS PRECLINICAL SCREENING PLATFORM FOR PAIN (PSPP)
Taleen Hanania · Psychogenics (United States) · funded by National Institutes of Health
2024–2026 · contract · N01
SCREENING OF INVESTIGATIONAL AGENTS THROUGH THE NINDS PRECLINICAL SCREENING PLATFORM FOR PAIN (PSPP)
Taleen Hanania · Psychogenics (United States) · funded by National Institutes of Health
2024–2026 · research · R44
EEG Signature Analysis for Drug Repurposing for Rare Diseases
Emer Leahy · Psychogenics (United States) · funded by National Institutes of Health
2023–2025 · research · R43
Machine Learning Phenotypic De Novo Drug Design
Daniela Brunner · Psychogenics (United States) · funded by National Institutes of Health
2023–2024 · contract · N01
TARGET ENGAGEMENT OF INVESTIGATIONAL AGENTS IN PSPP
Afshin Ghavami · Psychogenics (United States) · funded by National Institutes of Health
2023–2026 · research · R43
Machine Learning Phenotypic De Novo Drug Design
Daniela Brunner · Psychogenics (United States) · funded by National Institutes of Health
2019–2021 · contract · N01
SCREENING OF INVESTIGATIONAL AGENTS THROUGH THE NINDS PRECLINICAL SCREENING PLATFORM FOR PAIN (PSPP)
Emer Leahy · Psychogenics (United States) · funded by National Institutes of Health
2019–2020 · research · R43
Development of a novel pharmaco-EEG based, high-throughput screening platform to facilitate drug discovery for psychiatric disorders
Steven Leiser · Psychogenics (United States) · funded by National Institutes of Health
2019–2024 · contract · N01
PSPP - IDENTIFICATION AND VALIDATION OF NOVEL PAIN RELATED ENDPOINTS, NOVEL ANIMAL MODELS OF PAIN AND PROFILING OF INVESTIGATIONAL AGENTS IN RODENT AND NON-RODENT [EXCLUDING (NHP)] SPECIES
Emer Leahy · Psychogenics (United States) · funded by National Institutes of Health
2019–2023 · contract · N01
SCREENING OF INVESTIGATIONAL AGENTS THROUGH THE NINDS PRECLINICAL SCREENING PLATFORM FOR PAIN (PSPP)
Emer Leahy · Psychogenics (United States) · funded by National Institutes of Health
2019–2024 · contract · N01
SCREENING OF INVESTIGATIONAL AGENTS THROUGH THE NINDS PRECLINICAL SCREENING PLATFORM FOR PAIN (PSPP)
Emer Leahy · Psychogenics (United States) · funded by National Institutes of Health
2019–2024 · contract · N01
SCREENING OF INVESTIGATIONAL AGENTS THROUGH THE NINDS PRECLINICAL SCREENING PLATFORM FOR PAIN (PSPP)
Emer Leahy · Psychogenics (United States) · funded by National Institutes of Health
2019–2021 · contract · N01
SCREENING OF INVESTIGATIONAL AGENTS THROUGH THE NINDS PRECLINICAL SCREENING PLATFORM FOR PAIN (PSPP)
Emer Leahy · Psychogenics (United States) · funded by National Institutes of Health
2019–2021 · research · R43
Development of a novel pharmaco-EEG based, high-throughput screening platform to facilitate drug discovery for psychiatric disorders
Steven Leiser · Psychogenics (United States) · funded by National Institutes of Health
2016 · research · Research Grant
Study of Alpha-synuclein in the Dorsal Neostriatum
Sylvie Ramboz · Psychogenics (United States) · funded by Michael J. Fox Foundation for Parkinson's Research